Four JP Drafts Related to Chromatography Published for Public Comments
Recommendation
6/7 October 2026
Dealing with different compendial methods
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has published four Japanese Pharmacopoeia (JP) drafts of General Tests and General Information related to Chromatography.
The following documents have been published:
- Draft of new General Test “<2.00> Chromatography”
- Draft of revised General Test “<2.01> Liquid Chromatography”
- Draft of revised General Test “<2.02> Gas Chromatography”
- Draft of new General Information “<G1-5-181> Control Strategies and Change Control Concepts at Each Stage of Chromatography Lifecycle” (Change Control in Lifecycle of Chromatography)
The four draft documents are available as a PDF file on the PMDA's website. The PMDA also published a Briefing Note in which the key points of these four drafts are summarised.
Comments can be submitted until November 30, 2021. For this purpose, a form for comments has to be downloaded and sent by e-mail after it has been filled in.
Related GMP News
28.09.2026The Relationship between the BP and the Ph. Eur.
28.09.2026New Japanese Pharmacopoeia Drafts (September 2026) Open for Public Comment
28.09.2026EMA publishes final ICH M13B Guideline and Q&A on Bioequivalence
16.09.2026USP-NF Publishes Responses to Comments on Stimuli Article on Apex Vessel Geometries